| Q51745467 | A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk. |
| Q36552000 | Angiotensin receptor blockers on the formularies of Medicare drug plans |
| Q37050954 | Association of Medicare Part D medication out-of-pocket costs with utilization of statin medications |
| Q34529920 | Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study |
| Q37194648 | Benzodiazepine use and expenditures for Medicare beneficiaries and the implications of Medicare Part D exclusions |
| Q34977603 | Coping strategies used by patients infected with hepatitis C virus who are facing medication costs. |
| Q36927439 | Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries |
| Q37191246 | Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes |
| Q44444710 | Cost-related nonadherence to prescribed medication therapy among Medicare Part D beneficiaries with end-stage renal disease |
| Q33587010 | Coverage of atypical antipsychotics among medicare drug plans in the state of washington: changes between 2007 and 2008. |
| Q35509973 | Did Medicare Part D reduce disparities? |
| Q37374576 | Digesting the doughnut hole |
| Q42576240 | Drug licenses: a new model for pharmaceutical pricing |
| Q36741634 | Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage |
| Q37236459 | Effect of an expenditure cap on low-income seniors' drug use and spending in a state pharmacy assistance program |
| Q33848964 | Entering and exiting the Medicare part D coverage gap: role of comorbidities and demographics |
| Q34454355 | Factors influencing cost-related nonadherence to medication in older adults: a conceptually based approach |
| Q33725773 | Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes |
| Q44982031 | How end-stage renal disease patients manage the Medicare Part D coverage gap. |
| Q35752951 | How patient cost-sharing trends affect adherence and outcomes: a literature review. |
| Q36666594 | Implementation of the Medicare Part D prescription drug benefit is associated with antiretroviral therapy interruptions |
| Q45122916 | Influence exerted on drug prescribing by patients' attitudes and expectations and by doctors' perception of such expectations: a cohort and nested case-control study |
| Q33235030 | Information and shared decision-making are top patients' priorities |
| Q41677088 | Is bigger better? An argument for very low starting doses. |
| Q38977081 | Medicare Part D coverage gap: race, gender, and cost-related medication nonadherence |
| Q79766626 | Medication access through patient assistance programs |
| Q37372058 | Medication assistance programs: do all in need benefit equally? |
| Q37171578 | Medication strategies used by Medicare beneficiaries who reach the Part D standard drug-benefit threshold |
| Q37355509 | Older patients' perceptions of medication importance and worth: an exploratory pilot study |
| Q37125842 | Out-of-pocket medication costs and use of medications and health care services among children with asthma |
| Q36417054 | Patients at-risk for cost-related medication nonadherence: a review of the literature |
| Q34390982 | Pharmaceutical cost management and access to psychotropic drugs: the U.S. context |
| Q24188009 | Pharmaceutical policies: effects of cap and co-payment on rational use of medicines |
| Q37380436 | Pharmaceuticals companies' medication assistance programs: potentially useful but too burdensome to use? |
| Q36869615 | Prescription drug cost sharing: associations with medication and medical utilization and spending and health. |
| Q36053545 | Provider views about responsibility for medication adherence and content of physician-older patient discussions |
| Q36416879 | Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study |
| Q46096016 | Role of health insurance coverage in women's access to prescription medicines |
| Q33931960 | Sensitivity of medication use to formulary controls in medicare beneficiaries: a review of the literature |
| Q33412577 | Systematic review on quality control for drug management programs: is quality reported in the literature? |
| Q41477116 | The Effect of a Cardiovascular Polypill Strategy on Pill Burden |
| Q36417035 | The demise of Oregon's Medically Needy program: effects of losing prescription drug coverage |
| Q35683030 | Variation in estimated Medicare prescription drug plan costs and affordability for beneficiaries living in different states |
| Q41652859 | What Strategies Do Physicians and Patients Discuss to Reduce Out-of-Pocket Costs? Analysis of Cost-Saving Strategies in 1,755 Outpatient Clinic Visits. |
| Q44333941 | What does the Medicare prescription drug legislation mean for the American cardiologist? |
| Q47565817 | What is in your wallet? A cluster randomized trial of the effects of showing comparative patient out-of-pocket costs on primary care prescribing for uncomplicated hypertension |
| Q34723262 | Who can't pay for health care? |